MARSHALL WACE, LLP - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q1 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$547,280
+35.5%
33,249
+273.5%
0.00%
-50.0%
Q4 2020$404,000
-81.2%
8,903
-84.8%
0.00%
-86.7%
Q2 2020$2,153,000
+2166.3%
58,445
+1894.0%
0.02%
+1400.0%
Q1 2020$95,000
-94.2%
2,931
-92.4%
0.00%
-94.1%
Q4 2018$1,628,000
-97.0%
38,821
-94.6%
0.02%
-92.6%
Q3 2018$53,874,000
+266.2%
713,572
+248.0%
0.23%
+4.1%
Q2 2018$14,712,000205,0490.22%
Other shareholders
REGENXBIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 847,424$13,948,59912.64%
Sonic GP LLC 518,079$8,527,5808.28%
MPM BioImpact LLC 656,718$10,809,5782.89%
Redmile Group, LLC 2,574,042$42,368,7312.02%
ArchPoint Investors 224,278$3,691,6161.41%
WS MANAGEMENT LLLP 618,131$10,174,4360.82%
Redwood Wealth Management Group, LLC 14,360$236,3660.28%
HARBOR CAPITAL ADVISORS, INC. 48,559$799,2810.17%
PRENTISS SMITH & CO INC 11,240$185,0100.14%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 36,522$601,1520.09%
View complete list of REGENXBIO INC shareholders